Dis-Chem plans, in its 2027 financial year, to tighten the span of control of its CEO and to shift from the founder-led cross-functional leadership to a structure that creates clearer lines of accountability, with 200 new roles set to be created in underinvested departments.
Dis-Chem Pharmacies' share price fell by over 8% on Friday following the announcement of a sharp decline in earnings per share and a substantial cut in dividends.
The share traded 8,9% lower on the JSE on Friday afternoon at R34,55, a price that was still marginally above the R31,33 that it traded at 12 months before.
Group revenue increased 9,3% to R42,8 billion. Basic earnings per share (EPS) dipped 17,1%, while headline earnings per share (HEPS) followed suit, falling by 17.3% to 113,7 cents.
The final dividend per share came to 15,92 cents, marking a drastic 42,8% decrease. The total dividenddeclined by 17,3% to 45,34 cents a share.
